Rik Ossenkoppele, PhD, is a distinguished associate professor in Translational Neuroscience, holding key positions as a Principal Investigator at both the Alzheimercenter Amsterdam of the Amsterdam UMC in the Netherlands and Lund University in Sweden. Dr. Ossenkoppele’s research is at the cutting edge of neuroimaging, fluid biomarkers, and cognition, with a particular focus on Alzheimer’s disease. Driven by a profound commitment to advancing the understanding and treatment of Alzheimer’s disease, his work aims to enhance diagnostic and prognostic methods in the near term, with the ultimate ambition of finding a cure for this devastating condition.
Dr. Ossenkoppele’s contributions to neuroscience have earned him numerous prestigious awards, including the European Grand Prix for Research on the Foundation of Alzheimer’s Disease, the Young Investigator Research Award from Alzheimer Nederland, and the Queen Silvia Research Prize. His innovative research has also been supported by significant grants, such as an ERC Starting Grant and various high-profile dementia research grants.
In addition to his research and teaching roles, Dr. Ossenkoppele serves on the editorial boards of Alzheimer’s Research & Therapy and the European Journal of Nuclear Medicine and Molecular Imaging. He is an active member of program committees for several prominent Alzheimer’s disease and Frontotemporal Dementia conferences and is the Chair of the Atypical Alzheimer’s Disease Professional Interest Area of the Alzheimer’s Association, where he continues to influence the future direction of research in neurodegenerative diseases.
